242
Views
3
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Incorporation of lutein and docosahexaenoic acid from dietary microalgae into the retina in quail

, , , , , , , , , , & show all
Pages 222-229 | Received 18 Jun 2014, Accepted 12 Sep 2014, Published online: 06 Feb 2015

References

  • Acar N, Berdeaux O, Grégoire S, Cabaret S, Martine L, Gain P, Thuret G, et al. 2012. Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids? PLoS ONE 7:e35102
  • Acar N, Berdeaux O, Juaneda P, Grégoire S, Cabaret S, Joffre C, Creuzot-Garcher CP, et al. 2009. Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma. Exp Eye Res 89:840–853
  • Al MD, van Houwelingen AC, Hornstra G. 2000. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 71:285S–291S
  • Augood C, Chakravarthy U, Young I, Vioque J, de Jong PTVM, Bentham G, Rahu M, et al. 2008. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr 88:398–406
  • Bhosale P, Serban B, Zhao DY, Bernstein PS. 2007. Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica. Biochemistry 46:9050–9057
  • Bone RA, Landrum JT, Guerra LH, Ruiz CA. 2003. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133:992–998
  • Breslow JL. 2006. N-3 fatty acids and cardiovascular disease. Am J Clin Nutr 83:1477S–1482S
  • Calder PC. 2012. Mechanisms of action of (n-3) fatty acids. J Nutr 142:592S–599S
  • Chew E, Clemons T, SanGiovanni J, Danis R, Ferris F, Elman M, Antoszyk A, et al. 2013. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (areds2) randomized clinical trial. JAMA 309:2005–2015
  • Christen WG, Schaumberg DA, Glynn RJ, Buring JE. 2011. Dietary {omega}-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol 129:921–929
  • Chucair AJ, Rotstein NP, Sangiovanni JP, During A, Chew EY, Politi LE. 2007. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci 48:5168–5177
  • Chung H, Rasmussen HM, Johnson EJ. 2004. Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr 134:1887–1893
  • Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM. 2010. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 35:335–351
  • Delcourt C, Carrière I, Cristol J, Lacroux A, Gerber M. 2007. Dietary fat and the risk of age-related maculopathy: the polanut study. Eur J Clin Nutr 61:1341–1344
  • Delcourt C, Carrière I, Delage M, Barberger-Gateau P, Schalch W. 2006. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the pola study. Invest Ophthalmol Vis Sci 47:2329–2335
  • Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509
  • Guedes AC, Amaro HM, Malcata FX. 2011. Microalgae as sources of high added-value compounds – a brief review of recent work. Biotechnol Prog 27:597–613
  • Hammond BRJ, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM. 1997. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38:1795–1801
  • Hooijmans CR, Pasker-de Jong PCM, de Vries RBM, Ritskes-Hoitinga M. 2012. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 28:191–209
  • Johnson EJ, Chung H, Caldarella SM, Snodderly DM. 2008. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr 87:1521–1529
  • Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM. 2000. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 71:1555–1562
  • Juaneda P, Rocquelin G. 1985. Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids 20:40–41
  • Khachik F. 2012. Partial synthesis of serum carotenoids and their metabolites. Acta Biochim Pol 59:75–78
  • Khachik F, de Moura FF, Zhao D, Aebischer C, Bernstein PS. 2002. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci 43:3383–3392
  • Kijlstra A, Tian Y, Kelly ER, Berendschot TTJM. 2012. Lutein: more than just a filter for blue light. Prog Retin Eye Res 31:303–315
  • Kim JE, Clark RM, Park Y, Lee J, Fernandez ML. 2012. Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet. Nutr Res Pract 6:113–119
  • Krinsky NI, Johnson EJ. 2005. Carotenoid actions and their relation to health and disease. Mol Aspects Med 26:459–516
  • Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. 1997. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 65:57–62
  • Lecerf J. 2010. Fatty acids and age-related macular degeneration. Cah Nutr Diét 45:144–150
  • Lyan B, Azaïs-Braesco V, Cardinault N, Tyssandier V, Borel P, Alexandre-Gouabau MC, Grolier P. 2001. Simple method for clinical determination of 13 carotenoids in human plasma using an isocratic high-performance liquid chromatographic method. J Chromatogr B Biomed Sci Appl 751:297–303
  • Morrison WR, Smith LM. 1964. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride–methanol. J Lipid Res 5:600–608
  • Ma L, Dou H, Wu Y, Huang Y, Huang Y, Xu X, Zou Z, Lin X. 2012. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr 107:350–359
  • Merle B, Delyfer M, Korobelnik J, Rougier M, Colin J, Malet F, Féart C, et al. 2011. Dietary omega-3 fatty acids and the risk for age-related maculopathy: the alienor study. Invest Ophthalmol Vis Sci 52:6004–6011
  • Merle BMJ, Delyfer M, Korobelnik J, Rougier M, Malet F, Féart C, Le Goff M, et al. 2013. High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration. J Nutr 143:505–511
  • Moilanen T, Nikkari T. 1981. The effect of storage on the fatty acid composition of human serum. Clin Chim Acta 114:111–116
  • Neuringer M, Sandstrom MM, Johnson EJ, Snodderly DM. 2004. Nutritional manipulation of primate retinas, i: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci 45:3234–3243
  • Obulesu M, Dowlathabad MR, Bramhachari PV. 2011. Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models. Neurochem Int 59:535–541
  • Renzi LM, Hammond BRJ, Dengler M, Roberts R. 2012. The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs. Lipids Health Dis 11:33
  • Ribaya-Mercado JD, Blumberg JB. 2004. Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr 23:567S–587S
  • Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, et al. 2004. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the veterans last study (lutein antioxidant supplementation trial). Optometry 75:216–230
  • Sangiovanni JP, Agrón E, Meleth AD, Reed GF, Sperduto RD, Clemons TE, Chew EY. 2009. {Omega}-3 long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the age-related eye disease study. Am J Clin Nutr 90:1601–1607
  • Sangiovanni JP, Chew EY, Agrón E, Clemons TE, Ferris FL, Gensler G, Lindblad AS, et al. 2008. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 126:1274–1279
  • Schnebelen C, Viau S, Grégoire S, Joffre C, Creuzot-Garcher CP, Bron AM, Bretillon L, Acar N. 2009. Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation. Ophthalmic Res 41:216–224
  • Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, et al. 1994. Dietary carotenoids, vitamins a, c, and e, and advanced age-related macular degeneration. Eye disease case-control study group. JAMA 272:1413–1420
  • Seddon JM, George S, Rosner B. 2006. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US twin study of age-related macular degeneration. Arch Ophthalmol 124:995–1001
  • Souied EH, Delcourt C, Querques G, Bassols A, Merle B, Zourdani A, Smith T, Benlian P. 2013. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study. Ophthalmology 128:1619–1631
  • Spolaore P, Joannis-Cassan C, Duran E, Isambert A. 2006. Commercial applications of microalgae. J Biosci Bioeng 101:87–96
  • Swanson D, Block R, Mousa SA. 2012. Omega-3 fatty acids epa and dha: health benefits throughout life. Adv Nutr 3:1–7
  • Sy C, Gleize B, Dangles O, Landrier J, Veyrat CC, Borel P. 2012. Effects of physicochemical properties of carotenoids on their bioaccessibility, intestinal cell uptake, and blood and tissue concentrations. Mol Nutr Food Res 56:1385–1397
  • Toomey MB, McGraw KJ. 2007. Modified saponification and HPLC methods for analyzing carotenoids from the retina of quail: implications for its use as a nonprimate model species. Invest Ophthalmol Vis Sci 48:3976–3982
  • Toyoda Y, Thomson LR, Langner A, Craft NE, Garnett KM, Nichols CR, Cheng KM, Dorey CK. 2002. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail. Invest Ophthalmol Vis Sci 43:1210–1221
  • Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hänninen O, Uusitupa MI. 1997. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 32:697–705
  • Wang W, Connor SL, Johnson EJ, Klein ML, Hughes S, Connor WE. 2007. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr 85:762–769
  • Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, et al. 2011. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52:8174–8178
  • Weisinger HS, Vingrys AJ, Sinclair AJ. 1995. Dietary manipulation of long-chain polyunsaturated fatty acids in the retina and brain of guinea pigs. Lipids 30:471–473
  • Whitehead AJ, Mares JA, Danis RP. 2006. Macular pigment: a review of current knowledge. Arch Ophthalmol 124:1038–1045

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.